A pharmaceutical formulation of cannabidiol significantly reduced the number of seizures experienced by children with Dravet syndrome, according to study findings being presented at the American ...

Please provide your email address to receive an email when new articles are posted on . Cannabidiol treatment was associated with median reduction of 67% to 99% in focal aware seizures. All ...

Epidiolex, a pharmaceutical formulation of cannabidiol (CBD), continued to show benefits for people with Lennox-Gastaut syndrome and Dravet syndrome, real-world data showed. Seizure frequency was ...

An FDA-approved, purified form of cannabidiol (Epidiolex, GW Pharmaceuticals) reduces seizure burden in children with drug-resistant epilepsy (DRE), a new review confirms. In a new systematic review ...

BALTIMORE -- Adjunctive cannabidiol, or CBD, (Epidiolex) met its primary endpoint of reducing seizures in patients with tuberous sclerosis complex (TSC), a rare and severe form of childhood-onset ...

PHILADELPHIA — New open-label data from the expanded-access treatment program involving the cannabidiol Epidiolex (GW Pharma) show the median reduction in frequency of convulsive seizures after 3 ...

DUBLIN, Dec. 5, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that eight abstracts, including four that are late-breaking, will be presented on Epidiolex ® (cannabidiol) ...

Research on epilepsy during the early 20 th century led to the discovery of treatments for symptomatic seizures, such as bromide, phenobarbital, and phenytoin. Furthermore, the development of the ...

The effect may be explained by a drug-drug interaction between cannabidiol and the anti-seizure medication clobazam. The form of epilepsy examined in the study is called Lennox-Gastaut syndrome.

MASON CITY, Iowa (KIMT) – It’s International Epilepsy Day and one local mom has a lot to celebrate. She explained how much her son has changed all thanks to a new treatment. Caleb Helland has been ...

LONDON and CARLSBAD, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (“GW”, “the Company” or “the Group”), world leader in discovering, developing and commercialising ...

Treatment with a pharmaceutical formulation of cannabidiol alongside other anti-epilepsy treatments helped to reduce the number of drop seizures - seizures which involve sudden falls due to loss of ...